It is being used to observe how this particular EVOO component reverses inflammatory parameters (elevated TNF-, IL-1, and IL-6) and inhibits the activation of TLR-4 and NK-kB pathways, which are related to intestinal permeability in obesity. The gene discussed is TNF; the disease is Obesity.